Tags

Type your tag names separated by a space and hit enter

Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review.
Travel Med Infect Dis. 2015 Jan-Feb; 13(1):31-47.TM

Abstract

International travellers with immunocompromising conditions such as human immunodeficiency virus (HIV) infection, solid organ transplantation (SOT) and haematopoietic stem cell transplantation (HSCT) are at a significant risk of travel-related illnesses from both communicable and non-communicable diseases, depending on the intensity of underlying immune dysfunction, travel destinations and activities. In addition, the choice of travel vaccinations, timing and protective antibody responses are also highly dependent on the underlying conditions and thus pose significant challenges to the health-care providers who are involved in pre-travel risk assessment. This review article provides a framework of understanding and approach to aforementioned groups of immunocompromised travellers regarding pre-travel risk assessment and management; in particular travel vaccinations, infectious and non-infectious disease risks and provision of condition-specific advice; to reduce travel-related mortality and morbidity.

Authors+Show Affiliations

Department of General Medicine, The Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: A.Aung@alfred.org.au.Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia; Department of Microbiology, The Alfred Hospital, Melbourne, Victoria, Australia.Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia; Department of Microbiology, The Alfred Hospital, Melbourne, Victoria, Australia; Monash University, Melbourne, Victoria, Australia.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25593039

Citation

Aung, A K., et al. "Travel Risk Assessment, Advice and Vaccinations in Immunocompromised Travellers (HIV, Solid Organ Transplant and Haematopoeitic Stem Cell Transplant Recipients): a Review." Travel Medicine and Infectious Disease, vol. 13, no. 1, 2015, pp. 31-47.
Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. Travel Med Infect Dis. 2015;13(1):31-47.
Aung, A. K., Trubiano, J. A., & Spelman, D. W. (2015). Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. Travel Medicine and Infectious Disease, 13(1), 31-47. https://doi.org/10.1016/j.tmaid.2014.12.007
Aung AK, Trubiano JA, Spelman DW. Travel Risk Assessment, Advice and Vaccinations in Immunocompromised Travellers (HIV, Solid Organ Transplant and Haematopoeitic Stem Cell Transplant Recipients): a Review. Travel Med Infect Dis. 2015 Jan-Feb;13(1):31-47. PubMed PMID: 25593039.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review. AU - Aung,A K, AU - Trubiano,J A, AU - Spelman,D W, Y1 - 2014/12/31/ PY - 2014/10/11/received PY - 2014/12/17/revised PY - 2014/12/19/accepted PY - 2015/1/17/entrez PY - 2015/1/17/pubmed PY - 2015/7/21/medline KW - Haematopoietic stem cell transplant KW - Human immunodeficiency virus KW - Infections KW - Risk management KW - Solid organ transplant SP - 31 EP - 47 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 13 IS - 1 N2 - International travellers with immunocompromising conditions such as human immunodeficiency virus (HIV) infection, solid organ transplantation (SOT) and haematopoietic stem cell transplantation (HSCT) are at a significant risk of travel-related illnesses from both communicable and non-communicable diseases, depending on the intensity of underlying immune dysfunction, travel destinations and activities. In addition, the choice of travel vaccinations, timing and protective antibody responses are also highly dependent on the underlying conditions and thus pose significant challenges to the health-care providers who are involved in pre-travel risk assessment. This review article provides a framework of understanding and approach to aforementioned groups of immunocompromised travellers regarding pre-travel risk assessment and management; in particular travel vaccinations, infectious and non-infectious disease risks and provision of condition-specific advice; to reduce travel-related mortality and morbidity. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/25593039/Travel_risk_assessment_advice_and_vaccinations_in_immunocompromised_travellers__HIV_solid_organ_transplant_and_haematopoeitic_stem_cell_transplant_recipients_:_A_review_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(14)00262-2 DB - PRIME DP - Unbound Medicine ER -